Maria Kołtowska‐Häggström

3.2k total citations
73 papers, 2.5k citations indexed

About

Maria Kołtowska‐Häggström is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Maria Kołtowska‐Häggström has authored 73 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Pediatrics, Perinatology and Child Health and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Maria Kołtowska‐Häggström's work include Growth Hormone and Insulin-like Growth Factors (63 papers), Pituitary Gland Disorders and Treatments (30 papers) and Childhood Cancer Survivors' Quality of Life (17 papers). Maria Kołtowska‐Häggström is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (63 papers), Pituitary Gland Disorders and Treatments (30 papers) and Childhood Cancer Survivors' Quality of Life (17 papers). Maria Kołtowska‐Häggström collaborates with scholars based in Sweden, United States and United Kingdom. Maria Kołtowska‐Häggström's co-authors include Anders Mattsson, John P. Monson, Peter Jönsson, Roger Abs, Gudmundur Johannsson, Helena Filipsson Nyström, Miklós Góth, Johan Verhelst, Patrick Wilton and Ulla Feldt‐Rasmussen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and The American Journal of Cardiology.

In The Last Decade

Maria Kołtowska‐Häggström

72 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Kołtowska‐Häggström Sweden	30	2.1k	457	391	345	339	73	2.5k
Sei Won Yang South Korea	25	866 0.4×	368 0.8×	512 1.3×	174 0.5×	585 1.7×	134	2.2k
Päivi Tapanainen Finland	28	799 0.4×	671 1.5×	330 0.8×	224 0.6×	276 0.8×	52	2.1k
Laurence Kennedy United States	28	1.7k 0.8×	114 0.2×	890 2.3×	204 0.6×	170 0.5×	76	2.5k
Andrew Bates United Kingdom	19	1.8k 0.8×	96 0.2×	692 1.8×	234 0.7×	147 0.4×	39	2.4k
Aida Lteif United States	27	954 0.4×	165 0.4×	536 1.4×	94 0.3×	352 1.0×	71	2.1k
Margaret Cristina da Silva Boguszewski Brazil	25	922 0.4×	860 1.9×	189 0.5×	76 0.2×	343 1.0×	89	2.0k
Diarmuid Smith Ireland	23	839 0.4×	86 0.2×	355 0.9×	177 0.5×	159 0.5×	93	1.8k
Nele Friedrich Germany	20	885 0.4×	114 0.2×	286 0.7×	259 0.8×	129 0.4×	52	1.6k
Michael C. Honigberg United States	23	333 0.2×	308 0.7×	309 0.8×	801 2.3×	181 0.5×	95	2.1k
Rachel Crowley Ireland	22	734 0.3×	115 0.3×	271 0.7×	61 0.2×	130 0.4×	92	1.8k

Countries citing papers authored by Maria Kołtowska‐Häggström

Since Specialization

Citations

This map shows the geographic impact of Maria Kołtowska‐Häggström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Kołtowska‐Häggström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Kołtowska‐Häggström more than expected).

Fields of papers citing papers by Maria Kołtowska‐Häggström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Kołtowska‐Häggström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Kołtowska‐Häggström. The network helps show where Maria Kołtowska‐Häggström may publish in the future.

Co-authorship network of co-authors of Maria Kołtowska‐Häggström

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Kołtowska‐Häggström. A scholar is included among the top collaborators of Maria Kołtowska‐Häggström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Kołtowska‐Häggström. Maria Kołtowska‐Häggström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gardner, Chris J., Anders Mattsson, Christina Daousi, et al.. (2015). GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database. European Journal of Endocrinology. 172(4). 371–381. 44 indexed citations

Freda, Pamela U., Murray B. Gordon, Nicky Kelepouris, et al.. (2014). Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy. Endocrine Practice. 21(3). 264–274. 59 indexed citations

Lely, A. J. van der, et al.. (2014). PO2-4: Pregnancy in acromegaly patients treated with pegvisomant. Growth Hormone & IGF Research. 24. S40–S40. 1 indexed citations

Feldt‐Rasmussen, Ulla, Georg Brabant, Dominique Maiter, et al.. (2013). Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak. European Journal of Endocrinology. 168(5). 733–743. 14 indexed citations

Tritos, Nicholas A., Amir H. Hamrahian, Donna King, et al.. (2012). Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult‐onset growth hormone deficiency – a KIMS database analysis. Clinical Endocrinology. 79(2). 178–184. 16 indexed citations

Busschbach, Jan J.V., Bruce H. R. Wolffenbuttel, Lieven Annemans, W. J. Meerding, & Maria Kołtowska‐Häggström. (2010). Deriving reference values and utilities for the QoL-AGHDA in adult GHD. The European Journal of Health Economics. 12(3). 243–252. 9 indexed citations

Bullinger, Monika, Maria Kołtowska‐Häggström, David E. Sandberg, et al.. (2009). Health-Related Quality of Life of Children and Adolescents with Growth Hormone Deficiency or Idiopathic Short Stature – Part 2: Available Results and Future Directions. Hormone Research in Paediatrics. 72(2). 74–81. 56 indexed citations

Kołtowska‐Häggström, Maria, Anders Mattsson, & Stephen M. Shalet. (2009). Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. European Journal of Endocrinology. 161(suppl_1). S51–S64. 37 indexed citations

Mattsson, Anders, et al.. (2008). Total and cause-specific mortality in patients from the KIMS database: direct evidence for a beneficial effect of GH replacement therapy on mortality in adult GH deficient patients. 16. 2 indexed citations

10.

Casanueva, Felipe F., Roger Abs, Vera Popović, et al.. (2008). Isolated GH deficiency of adult-onset in the KIMS database: prevalence, clinical presentation, and response to GH replacement. 16.

11.

Friedrich, Nele, Henry Völzke, Matthias Nauck, et al.. (2008). Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania. European Journal of Endocrinology. 160(1). 17–24. 26 indexed citations

12.

Monson, John P., Peter Jönsson, Maria Kołtowska‐Häggström, & IONE A. KOURIDES. (2007). Growth hormone (GH) replacement decreases serum total and LDL‐cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy. Clinical Endocrinology. 67(4). 623–628. 35 indexed citations

13.

Kołtowska‐Häggström, Maria, Paul Kind, John P. Monson, & Björn Jonsson. (2007). Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility‐weighted quality of life index: a precursor to cost–utility analysis. Clinical Endocrinology. 68(1). 122–129. 19 indexed citations

14.

Svensson, Johan, Nick Finer, Pierre Bouloux, et al.. (2007). Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response. Growth Hormone & IGF Research. 17(1). 67–76. 22 indexed citations

15.

Höybye, Charlotte, Peter Jönsson, John P. Monson, et al.. (2007). Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency. European Journal of Endocrinology. 157(5). 589–596. 15 indexed citations

16.

Saller, Bernhard, Anders Mattsson, Peter Herbert Kann, et al.. (2006). Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults – comparison between Sweden, The Netherlands and Germany. European Journal of Endocrinology. 154(6). 843–850. 35 indexed citations

17.

Kołtowska‐Häggström, Maria, et al.. (2005). Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Comparison of Normative Reference Data for the General Population of England and Wales with Results for Adult Hypopituitary Patients with Growth Hormone Deficiency. Hormone Research in Paediatrics. 64(1). 46–54. 40 indexed citations

18.

Abs, Roger, Anders Mattsson, Bengt‐Åke Bengtsson, et al.. (2005). Isolated growth hormone (GH) deficiency in adult patients: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Hormone & IGF Research. 15(5). 349–359. 70 indexed citations

19.

Kind, P & Maria Kołtowska‐Häggström. (2004). Incorporating social preferences in the measurement of QoL outcomes in growth hormone deficiency (GHD) in adults. 7. 1 indexed citations

20.

Geffner, Mitchell E., Michael Lundberg, Maria Kołtowska‐Häggström, et al.. (2004). Changes in Height, Weight, and Body Mass Index in Children with Craniopharyngioma after Three Years of Growth Hormone Therapy: Analysis of KIGS (Pfizer International Growth Database). The Journal of Clinical Endocrinology & Metabolism. 89(11). 5435–5440. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact